特里巴诺索马提德细胞外囊泡作为沙加斯病潜在免疫原体
Juliana Bernardi Aggio1, Verônica Vitória Vedam1,2, Líndice Mitie Nisimura1,3
1Instituto Carlos Chagas, Fundação Oswaldo Cruz (FIOCRUZ-PR), Curitiba 81350-010, Brazil.
International journal of molecular sciences
|February 26, 2025
概括
来自Trypanosoma rangeli和Phytomonas serpens等非致病性寄生虫的细胞外囊泡 (EV) 显示出降低Trypanosoma cruzi寄生虫负载的潜力. 然而,这些EV并没有改善对查加斯病的生存率,这表明其保护性有效性有限.
科学领域:
- 寄生虫学的寄生虫学
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 查加斯病是一个重大的公共卫生挑战,治疗选择很少.
- 来自Trypanosoma cruzi的细胞外囊泡 (EV) 通常通过调节宿主免疫力来促进寄生虫的生存.
- 迫切需要针对夏加斯病的新型预防策略.
研究的目的:
- 来自非致病性Trypanosoma rangeli和Phytomonas serpens的EV的特征.
- 评估它们作为对Trypanosoma cruzi感染的交叉保护性免疫原体的潜力.
- 为了比较它们的免疫性质与来自T. cruzi.的EV.
主要方法:
- 使用纳米粒子追踪分析和电子显微镜进行EV隔离和表征.
- 通过LC-MS/MS对EV进行比较蛋白质组分析.
- 使用PBMC和BALB/c小鼠进行体外和体内测定,以评估免疫调节和对T. cruzi的保护.
主要成果:
- 蛋白质组分析显示,T. rangeli,P. serpens和T. cruzi. 的EV之间共享的蛋白质,包括卡尔帕因类的氨酸酶和延长因子2.
- 在体外,T. rangeli EVs降低了T. cruzi宿主细胞感染率.
- 在体内,用T. rangeli和P. serpens EVs免疫接种显著减少了与T. cruzi挑战的小鼠的寄生病,但没有改善生存率.
结论:
- 非致病性试索马提德EV具有免疫性质,可以降低寄生虫负载.
- 目前基于EV的策略在预防查加斯病的进展和死亡率方面表现出有限的有效性.
- 需要进一步的研究来优化基于EV的方法,以获得有效的查加斯病免疫力.
相关概念视频
Diversity of Protists I
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


